584 related articles for article (PubMed ID: 25639676)
1. Tolerogenic dendritic cells: role and therapeutic implications in systemic lupus erythematosus.
Mok MY
Int J Rheum Dis; 2015 Feb; 18(2):250-9. PubMed ID: 25639676
[TBL] [Abstract][Full Text] [Related]
2. Rel B-modified dendritic cells possess tolerogenic phenotype and functions on lupus splenic lymphocytes in vitro.
Wu H; Lo Y; Chan A; Law KS; Mok MY
Immunology; 2016 Sep; 149(1):48-61. PubMed ID: 27278094
[TBL] [Abstract][Full Text] [Related]
3. Induction of tolerogenic dendritic cells by NF-κB blockade and Fcγ receptor modulation.
Carreño LJ; Riedel CA; Kalergis AM
Methods Mol Biol; 2011; 677():339-53. PubMed ID: 20941620
[TBL] [Abstract][Full Text] [Related]
4. Tolerogenic dendritic cells as a therapy for treating lupus.
Llanos C; Mackern-Oberti JP; Vega F; Jacobelli SH; Kalergis AM
Clin Immunol; 2013 Aug; 148(2):237-45. PubMed ID: 23773922
[TBL] [Abstract][Full Text] [Related]
5. Hormonal Modulation of Dendritic Cells Differentiation, Maturation and Function: Implications for the Initiation and Progress of Systemic Autoimmunity.
Mackern-Oberti JP; Jara EL; Riedel CA; Kalergis AM
Arch Immunol Ther Exp (Warsz); 2017 Apr; 65(2):123-136. PubMed ID: 27585815
[TBL] [Abstract][Full Text] [Related]
6. Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus.
Blanco P; Palucka AK; Gill M; Pascual V; Banchereau J
Science; 2001 Nov; 294(5546):1540-3. PubMed ID: 11711679
[TBL] [Abstract][Full Text] [Related]
7. Contribution of dendritic cells to the autoimmune pathology of systemic lupus erythematosus.
Mackern-Oberti JP; Llanos C; Riedel CA; Bueno SM; Kalergis AM
Immunology; 2015 Dec; 146(4):497-507. PubMed ID: 26173489
[TBL] [Abstract][Full Text] [Related]
8. Defective expression and function of the ILT2/CD85j regulatory receptor in dendritic cells from patients with systemic lupus erythematosus.
Monsiváis-Urenda A; Gómez-Martin D; Santana-de-Anda K; Cruz-Martínez J; Alcocer-Varela J; González-Amaro R
Hum Immunol; 2013 Sep; 74(9):1088-96. PubMed ID: 23756160
[TBL] [Abstract][Full Text] [Related]
9. Immune complex enhances tolerogenecity of immature dendritic cells via FcγRIIb and promotes FcγRIIb-overexpressing dendritic cells to attenuate lupus.
Zhang Y; Liu S; Yu Y; Zhang T; Liu J; Shen Q; Cao X
Eur J Immunol; 2011 Apr; 41(4):1154-64. PubMed ID: 21360699
[TBL] [Abstract][Full Text] [Related]
10. Intravenous immunoglobulin abrogates dendritic cell differentiation induced by interferon-alpha present in serum from patients with systemic lupus erythematosus.
Bayry J; Lacroix-Desmazes S; Delignat S; Mouthon L; Weill B; Kazatchkine MD; Kaveri SV
Arthritis Rheum; 2003 Dec; 48(12):3497-502. PubMed ID: 14674000
[TBL] [Abstract][Full Text] [Related]
11. A Plasmacytoid Dendritic Cells-Type I Interferon Axis Is Critically Implicated in the Pathogenesis of Systemic Lupus Erythematosus.
Kim JM; Park SH; Kim HY; Kwok SK
Int J Mol Sci; 2015 Jun; 16(6):14158-70. PubMed ID: 26110387
[TBL] [Abstract][Full Text] [Related]
12. Adoptive transfer of autoimmune splenic dendritic cells to lupus-prone mice triggers a B lymphocyte humoral response.
Sauma D; Crisóstomo N; Fuentes C; Gleisner MA; Hidalgo Y; Fuenzalida MJ; Rosemblatt M; Bono MR
Immunol Res; 2017 Aug; 65(4):957-968. PubMed ID: 28741259
[TBL] [Abstract][Full Text] [Related]
13. Dendritic cells as key players in systemic lupus erythematosus.
Kaewraemruaen C; Ritprajak P; Hirankarn N
Asian Pac J Allergy Immunol; 2020 Dec; 38(4):225-232. PubMed ID: 31837212
[TBL] [Abstract][Full Text] [Related]
14. Autologous tolerogenic dendritic cells derived from monocytes of systemic lupus erythematosus patients and healthy donors show a stable and immunosuppressive phenotype.
Obreque J; Vega F; Torres A; Cuitino L; Mackern-Oberti JP; Viviani P; Kalergis A; Llanos C
Immunology; 2017 Dec; 152(4):648-659. PubMed ID: 28763099
[TBL] [Abstract][Full Text] [Related]
15. Blood dendritic cells in systemic lupus erythematosus exhibit altered activation state and chemokine receptor function.
Gerl V; Lischka A; Panne D; Grossmann P; Berthold R; Hoyer BF; Biesen R; Bruns A; Alexander T; Jacobi A; Dörner T; Burmester GR; Radbruch A; Hiepe F
Ann Rheum Dis; 2010 Jul; 69(7):1370-7. PubMed ID: 19854711
[TBL] [Abstract][Full Text] [Related]
16. Role of dendritic cells in the initiation, progress and modulation of systemic autoimmune diseases.
Mackern-Oberti JP; Llanos C; Vega F; Salazar-Onfray F; Riedel CA; Bueno SM; Kalergis AM
Autoimmun Rev; 2015 Feb; 14(2):127-39. PubMed ID: 25449681
[TBL] [Abstract][Full Text] [Related]
17. Interferon regulatory factor 5 is critical for the development of lupus in MRL/lpr mice.
Tada Y; Kondo S; Aoki S; Koarada S; Inoue H; Suematsu R; Ohta A; Mak TW; Nagasawa K
Arthritis Rheum; 2011 Mar; 63(3):738-48. PubMed ID: 21305501
[TBL] [Abstract][Full Text] [Related]
18. The role of dead cell clearance in the etiology and pathogenesis of systemic lupus erythematosus: dendritic cells as potential targets.
Biermann MH; Veissi S; Maueröder C; Chaurio R; Berens C; Herrmann M; Munoz LE
Expert Rev Clin Immunol; 2014 Sep; 10(9):1151-64. PubMed ID: 25081199
[TBL] [Abstract][Full Text] [Related]
19. Distinct roles of myeloid and plasmacytoid dendritic cells in systemic lupus erythematosus.
Chan VS; Nie YJ; Shen N; Yan S; Mok MY; Lau CS
Autoimmun Rev; 2012 Oct; 11(12):890-7. PubMed ID: 22503660
[TBL] [Abstract][Full Text] [Related]
20. Tolerogenic dendritic cell transfer ameliorates systemic lupus erythematosus in mice.
Funes SC; Ríos M; Gómez-Santander F; Fernández-Fierro A; Altamirano-Lagos MJ; Rivera-Perez D; Pulgar-Sepúlveda R; Jara EL; Rebolledo-Zelada D; Villarroel A; Roa JC; Mackern-Oberti JP; Kalergis AM
Immunology; 2019 Dec; 158(4):322-339. PubMed ID: 31509246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
